Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma

21 Apr 2021

Abstract excerpt

= 31) groups. Three differential expression genes (DEGs) and five prognostic m6A genes were screened out. M6A-related risk signature (RBM15 and HNRNPC) was constructed by the Lasso regression analysis. In TCGA cohort (training cohort), the risk signature was identified as an ACC-independent prognostic factor and can distinguish the prognostic difference of ACC patients with clinical stage I-II, T3-4 and N0...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Hypoxia, and Metabolism
Share to Cardiac tumors and thrombi
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33952721
DOI: 10.18632/aging.202896

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinomaPMID 33952721Read ↗

A four-m6A methylation regulator risk score was an independent prognostic biomarker for adrenocortical carcinomaSemantic proximity Read ↗

Analysis of m6A-Related Signatures in the Tumor Immune Microenvironment and Identification of Clinical Prognostic Regulators in Adrenocortical Carcinoma.Semantic proximity Read ↗

Elucidating the clinical and immunological value of m6A regulator-mediated methylation modification patterns in adrenocortical carcinomaSemantic proximity Read ↗

Construction of a m6A RNA Methylation Regulator-related Signature for Prognosis and Immune Response in Lung AdenocarcinomaSemantic proximity Read ↗

Analysis of m7G-Related Signatures in Adrenocortical Carcinoma and Their Correlation with SurvivalSemantic proximity Read ↗

Identification and validation of a novel prognosis prediction model in adrenocortical carcinoma by integrative bioinformatics analysis and statistics and machine learningSemantic proximity Read ↗

Construction of an m6A-related lncRNA model for predicting prognosis and immunotherapy in patients with lung adenocarcinomaSemantic proximity Read ↗

Expression Status and Prognostic Value of m6A RNA Methylation Regulators in Lung AdenocarcinomaSemantic proximity Read ↗

Molecular characterization and prognostic relevance of m6A regulators in pancreatic adenocarcinomaSemantic proximity Read ↗

Characteristic of Classification and Prognostic Scoring Based on M6a RNA Methylation Modification in Lung Adenocarcinoma and Tumor Microenvironment AssociationSemantic proximity Read ↗

M6a Regulator-Mediated RNA Methylation modification Patterns Correlated With Prognosis Value and Immune Response in Adenocarcinoma of lungSemantic proximity Read ↗

The m6A/m5C/m1A regulator genes signature reveals the prognosis and is related with immune microenvironment for hepatocellular carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.